Literature DB >> 20810527

Discontinuation of etanercept after successful treatment in patients with juvenile idiopathic arthritis.

Agustin Remesal, Jaime DE Inocencio, Rosa Merino, Julia Garcia-Consuegra.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20810527     DOI： 10.3899/jrheum.100219

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  6 in total

1.  Attitudes and Approaches for Withdrawing Drugs for Children with Clinically Inactive Nonsystemic JIA: A Survey of the Childhood Arthritis and Rheumatology Research Alliance.

Authors:  Daniel B Horton; Karen B Onel; Timothy Beukelman; Sarah Ringold
Journal:  J Rheumatol       Date:  2017-02-01       Impact factor: 4.666

2.  Cost of biologics in the treatment of juvenile idiopathic arthritis: a factor not to be overlooked.

Authors:  Femke H M Prince; Lisette W A van Suijlekom-Smit
Journal:  Paediatr Drugs       Date:  2013-08       Impact factor: 3.022

3.  Evaluation of flare rate and reduction strategies for bDMARDs in juvenile idiopathic arthritis: real world data from a single-centre cohort.

Authors:  Antía García-Fernández; Andrea Briones-Figueroa; Laura Calvo-Sanz; África Andreu-Suárez; Alina Boteanu
Journal:  Rheumatol Int       Date:  2022-03-19       Impact factor: 2.631

4.  Non-systemic juvenile idiopathic arthritis outcome after reaching clinical remission with anti-TNF-α therapy: a clinical practice observational study of patients who discontinued treatment.

Authors:  Estíbaliz Iglesias; Vicenç Torrente-Segarra; Rosa Bou; Silvia Ricart; María Isabel González; Judith Sánchez; Joan Calzada; Jordi Antón
Journal:  Rheumatol Int       Date:  2013-10-26       Impact factor: 2.631

5.  Treatment Withdrawal Following Remission in Juvenile Idiopathic Arthritis: A Systematic Review of the Literature.

Authors:  Olha Halyabar; Jay Mehta; Sarah Ringold; Dax G Rumsey; Daniel B Horton
Journal:  Paediatr Drugs       Date:  2019-12       Impact factor: 3.022

6.  Clinical remission in juvenile idiopathic arthritis after termination of etanercept.

Authors:  Jacek Postępski; Katarzyna Kobusińska; Edyta Olesińska; Violetta Osińska; Violetta Opoka-Winiarska
Journal:  Rheumatol Int       Date:  2012-07-21       Impact factor: 2.631
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.